Anders Kronborg

Part of LEO Fondet, LEO Laboratories Ltd. is a British dermatology company that aims to improve the lives of people living with a dermatological condition. The company is based in Hurley, UK. LEO Laboratories supplies treatments to people with medical needs in more than 130 countries around the world and strives to positively impact the lives of 125 million people through medical dermatology by 2025. Founded in 1960 and headquartered in Denmark, the company currently employs 6,000 professionals across 60 countries.

Kinnevik New Ventures AB. (KNV) is a venture capital subsidiary of Kinnevik AB founded in 1936. The firm is headquartered in Stockholm, Sweden.

G3 Good Governance Holdings Ltd. provides strategic advisory services. The private company is based in London, UK.

Part of Kinnevik AB, Recovia AB is a Swedish company that specializes in renewable and sustainable energy. Recovia is based in Stockholm, Sweden. Recovia owns and operates installations that have abated greenhouse gas emissions corresponding to several hundreds of thousands of tons of CO2. The company develops projects in landfill gas to power and sells renewable power. Recovia is also developing gasification projects and renewable hydrogen based on new technologies. The company's philosophy is to recover as much economic value and energy as possible from waste streams. The company was founded in 2010 by Warren Campbell and Fredrik Carlman, who has been the CEO since then.

ResoTher Pharma is a privately held clinical-stage biotech company based in Copenhagen, Denmark. ResoTher Pharma focuses on developing compounds that induce inflammatory resolution in cardiovascular diseases. The Danish company's lead compound, RTP-026, has shown to have a profound effect on reducing infarction size and restoring cardiac function to a pre-infarction level. ResoTher Pharma's mission is to create novel medicines that benefit patients in need by addressing unmet needs in CVD inflammation through endogenous immune regulatory pathways. The company was founded in 2016 by Thomas Jonassen and is privately owned by a group of prominent Danish investors.

FB Dermatology Ltd. is a med-tech company, which focuses on developing and exploring patented bio-photonic technology using fluorescent light energy to stimulate the skin’s own biological processes and repair mechanisms. Its products include Kleresca acne treatment, Kleresca skin rejuvenation, Kleresca rosacea treatment, and Kleresca pre-post Treasureratment. The company is headquartered in Dublin, Ireland.